EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Elevated Soluble ACE2 Activity in Children and Adults After SARS‐CoV‐2 Exposure Irrespective of Laboratory‐Confirmed Infection

Maximilian Stich iD, Vladimir Gonçalves Magalhães iD, Friederike Bürger, Sven F Garbade iD, Kathrin Jeltsch iD, Kerstin Mohr, Anneke Haddad iD, Roland Elling iD, Peter Lang iD, Armin Rabsteyn iD, Eva-Maria Jacobsen iD, Sebastian F N Bode iD und 9 weitere

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.70098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Maximilian Stich und 20 weiteren Autor:innen. Beteiligte Einrichtung: Heidelberg University, Medical Faculty Heidelberg, Center for Pediatric and Adolescent Medicine, Department of Pediatrics I, Heidelberg, Germany. Hauptthemen laut MEDLINE: COVID-19, Angiotensin-Converting Enzyme 2, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The study was funded by the Ministry of Science, Research and the Arts in Baden-Württemberg, Germany, within the framework of the special funding line for COVI….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pivotal role of the cell entry receptor ACE2 for SARS‐CoV‐2 infection is well‐established. When ACE2 is shed from cell surface into plasma as soluble ACE2 (sACE2), it can effectively neutralize SARS‐CoV‐2. This longitudinal prospective cohort study analyzed sACE2 activity in 1192 participants, aged 4 months to 81 years, 3 and 12 months after SARS‐CoV‐2 household exposure. Following SARS‐CoV‐2 exposure, participants exhibited significantly elevated sACE2 activity, irrespective of confirmed infection, with the highest levels observed in exposed children. Longitudinal analysis revealed a decline in sACE2 levels over time, reaching levels comparable to age‐ and sex‐matched pre‐pandemic controls. An increase in sACE2 activity was also confirmed in vitro in Calu‐3 (human lung) cells within hours of SARS‐CoV‐2 exposure, providing a direct link between SARS‐CoV‐2 exposure and elevated sACE2. This study, therefore, challenges the dichotomy of categorizing SARS‐CoV‐2 exposed participants as infected or not infected solely on currently established diagnostic assays. It demonstrates lasting host responses independent of B‐ and T‐cell memory and may help to keep SARS‐CoV‐2 infections in balance and contribute to successful virus clearance in children and adults lacking humoral and cellular immune responses following SARS‐CoV‐2 exposure. Trial Registration: German Registry for Clinical Studies; Identifier: D 00021521.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Angiotensin-Converting Enzyme 2SARS-CoV-2HumansChildChild, PreschoolMaleAdultFemaleAdolescentInfantMiddle AgedProspective StudiesYoung AdultAgedLongitudinal StudiesAged, 80 and over

Stichwörter der Autor:innen

ACE2SARS‐CoV‐2childrenexposurepersistence

Substanzen

Angiotensin-Converting Enzyme 2ACE2 protein, human

Autor:innen und Institutionen

  • Heidelberg University, Medical Faculty Heidelberg, Center for Pediatric and Adolescent Medicine, Department of Pediatrics I, Heidelberg, Germany.
  • Heidelberg University, Medical Faculty Heidelberg, Department of Infectious Diseases, Molecular Virology, Heidelberg, Germany.
  • German Cancer Research Center (DKFZ), Division Virus-Associated Carcinogenesis, Heidelberg, Germany.
  • German Center for Infection Research (DZIF), Heidelberg Partner Site, Heidelberg, Germany.
  • German Cancer Research Center (DKFZ), Division Virus-Associated Carcinogenesis, Research Group "Dynamics of Early Viral Infection and the Innate Antiviral Response", Heidelberg, Germany.
  • Institute for Infection Prevention and Control, University Medical Centre and Faculty of Medicine Freiburg, Freiburg im Breisgau, Germany.

ORCID-Profile: Maximilian Stich, Vladimir Gonçalves Magalhães, Sven F Garbade, Kathrin Jeltsch, Anneke Haddad, Roland Elling, Peter Lang, Armin Rabsteyn, Eva-Maria Jacobsen, Sebastian F N Bode, Barbara Müller, Hans-Georg Kräusslich, Georg Friedrich Hoffmann, Ralf Bartenschlager, Marco Binder, Aleš Janda, Hanna Renk, Burkhard Tönshoff

Förderung

  • The study was funded by the Ministry of Science, Research and the Arts in Baden-Württemberg, Germany, within the framework of the special funding line for COVI…

Zitieren

APA

Stich, M., Magalhães, V. G., Bürger, F., Garbade, S. F., Jeltsch, K., Mohr, K., Haddad, A., Elling, R., Lang, P., Rabsteyn, A., Jacobsen, E. M., Bode, S. F. N., Müller, B., Kräusslich, H. G., Hoffmann, G. F., Okun, J. G., Bartenschlager, R., Binder, M., Janda, A., …, & Tönshoff, B. (2024). Elevated Soluble ACE2 Activity in Children and Adults After SARS‐CoV‐2 Exposure Irrespective of Laboratory‐Confirmed Infection. Journal of Medical Virology. https://doi.org/10.1002/jmv.70098

Vancouver

Stich M, Magalhães VG, Bürger F, Garbade SF, Jeltsch K, Mohr K, et al. Elevated Soluble ACE2 Activity in Children and Adults After SARS‐CoV‐2 Exposure Irrespective of Laboratory‐Confirmed Infection. Journal of Medical Virology. 2024. doi:10.1002/jmv.70098

BibTeX
@article{Stich2024,
  author = {Stich, Maximilian and Magalhães, Vladimir Gonçalves and Bürger, Friederike and Garbade, Sven F and Jeltsch, Kathrin and Mohr, Kerstin and Haddad, Anneke and Elling, Roland and Lang, Peter and Rabsteyn, Armin and Jacobsen, Eva-Maria and Bode, Sebastian F N and Müller, Barbara and Kräusslich, Hans-Georg and Hoffmann, Georg Friedrich and Okun, Jürgen G and Bartenschlager, Ralf and Binder, Marco and Janda, Aleš and Renk, Hanna and Tönshoff, Burkhard},
  title = {Elevated Soluble ACE2 Activity in Children and Adults After SARS‐CoV‐2 Exposure Irrespective of Laboratory‐Confirmed Infection},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.70098}
}
Kostenlos starten →